1-7 of 7
Werner Hoellriegl, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AAV8-Specific Immune Adsorption Column: A Treatment Option for Patients with Pre-Existing Anti-AAV8 Neutralizing Antibodies

Anita Kruzik, PhD, Roland Raim, PhD, Dirk Voelkel, PhD, Markus Weiller, PhD, Werner Hoellriegl, PhD, Friedrich Scheiflinger, Hanspeter Rottensteiner, Birgit M Reipert, PhD, Maurus de la Rosa
Journal: Blood
Blood (2019) 134 (Supplement_1): 5922.
https://doi.org/10.1182/blood-2019-126730
Published: 2019
Journal Articles

The Factor VIII Variant X5 Enhances Hemophilia a Gene Therapy Efficiency By Its Improved Secretion

Franziska Horling, PhD, Johannes Lengler, PhD, Wenjing Cao, PhD, Biao Dong, PhD, Bagirath Gangadharan, Maurus De La Rosa, PhD, Werner Hoellriegl, PhD, Birgit M Reipert, PhD, Friedrich Scheiflinger, Weidong Xiao, PhD, Hanspeter Rottensteiner
Journal: Blood
Blood (2019) 134 (Supplement_1): 3356.
https://doi.org/10.1182/blood-2019-126489
Published: 2019
Journal Articles

A TFPI Inhibitory Half Life Extended Fusion Peptide Proves Efficacy in FVIII Knock out Mice and Marmoset Monkeys

Michael Dockal, PhD, Rudolf Hartmann, PhD, Thomas Polakowski, PhD, Erwin Panholzer, Willibald Kammlander, Frank Osterkamp, PhD, Ulrich Reineke, PhD, Alexandra Schiviz, PhD, Werner Hoellriegl, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2014) 124 (21): 1469.
https://doi.org/10.1182/blood.V124.21.1469.1469
Published: 2014
Journal Articles

Concomitant Administration Of Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII At Low Doses Are Efficacious and Safe In Hemophilic Mice

Michael Dockal, PhD, Sabine Knappe, PhD, Peter Leidenmuehler, Christina Piskernik, DVM, Sylvia Tippl, Marlene Resch, DVM, Dagmar Verdino, DVM, Alexander Bauer, Werner Hoellriegl, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2013) 122 (21): 2353.
https://doi.org/10.1182/blood.V122.21.2353.2353
Published: 2013
Journal Articles

Preclinical Efficacy Testing of Baxter's Recombinant ADAMTS13 in a Mouse Model of TTP.

Alexandra Schiviz, DVM, Marlene Resch, DVM, Elisa Farnleitner, Hanspeter Rottensteiner, PhD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Werner Hoellriegl, PhD, Eva-Maria Muchitsch, DVM
Journal: Blood
Blood (2012) 120 (21): 2216.
https://doi.org/10.1182/blood.V120.21.2216.2216
Published: 2012
Journal Articles

Impact of Factor IXa Content On Function, Safety and Efficacy of Recombinant Factor IX Products.

Wilfried Auer, PhD, Hanspeter Rottensteiner, PhD, Gerald Schrenk, PhD, Werner Hoellriegl, PhD, Alexandra Schiviz, DVM, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Peter L Turecek, PhD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2012) 120 (21): 2233.
https://doi.org/10.1182/blood.V120.21.2233.2233
Published: 2012
Journal Articles

Preclinical Efficacy Testing of Baxter's Recombinant FVIIa

Alexandra Schiviz, PhD, John-Philip Lawo, PhD, Marlene Resch, Peter Leidenmuehler, Bettina Bischetsrieder, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Werner Hoellriegl, PhD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2010) 116 (21): 4659.
https://doi.org/10.1182/blood.V116.21.4659.4659
Published: 2010